BACKGROUND: CAPAP, the activation peptide of procarboxypeptidase B, is a predictor of severe acute pancreatitis (AP). Active carboxypeptidase (aCAP) may be a better predictor, as its turnover is slower. Monocyte chemotactic protein-1 (MCP-1) is an early inflammatory marker and increases before complications in severe AP. We conducted a cohort study to evaluate these markers as predictors for severe AP. METHOD: 140 patients with AP were included, retrospectively grouped as severe or mild by the Atlanta classification. CAPAP, MCP-1 and aCAP were analyzed in admission samples. Receiver operating characteristic curves determined high vs. low levels. RESULTS: The levels of all markers were significantly higher in patients with severe disease. High levels of serum MCP-1 was associated with a high risk of developing severe AP (OR 40.8; 95% CI 8.5-195). High ORs were also seen for urine MCP-1 (OR 7.3; 95% CI 2.2-24.3), serum CAPAP (OR 5.4; 95% CI 1.6-17.7), urine CAPAP (OR 4.8; 95% CI 1.6-14.2), and serum aCAP (OR 3.7; 95% CI 1.2-11.3). CONCLUSION: Serum MCP-1 at admission was strongly associated with development of severe AP. MCP-1 in urine, CAPAP in serum and urine and aCAP may also be useful for predicting severe AP. and IAP. Copyright 2008 S. Karger AG, Basel.
BACKGROUND:CAPAP, the activation peptide of procarboxypeptidase B, is a predictor of severe acute pancreatitis (AP). Active carboxypeptidase (aCAP) may be a better predictor, as its turnover is slower. Monocyte chemotactic protein-1 (MCP-1) is an early inflammatory marker and increases before complications in severe AP. We conducted a cohort study to evaluate these markers as predictors for severe AP. METHOD: 140 patients with AP were included, retrospectively grouped as severe or mild by the Atlanta classification. CAPAP, MCP-1 and aCAP were analyzed in admission samples. Receiver operating characteristic curves determined high vs. low levels. RESULTS: The levels of all markers were significantly higher in patients with severe disease. High levels of serum MCP-1 was associated with a high risk of developing severe AP (OR 40.8; 95% CI 8.5-195). High ORs were also seen for urine MCP-1 (OR 7.3; 95% CI 2.2-24.3), serum CAPAP (OR 5.4; 95% CI 1.6-17.7), urine CAPAP (OR 4.8; 95% CI 1.6-14.2), and serum aCAP (OR 3.7; 95% CI 1.2-11.3). CONCLUSION: Serum MCP-1 at admission was strongly associated with development of severe AP. MCP-1 in urine, CAPAP in serum and urine and aCAP may also be useful for predicting severe AP. and IAP. Copyright 2008 S. Karger AG, Basel.
Authors: Mukund P Srinivasan; Kamlesh K Bhopale; Anna A Caracheo; Samir M Amer; Shamis Khan; Lata Kaphalia; Gopalakrishnan Loganathan; Appakalai N Balamurugan; Bhupendra S Kaphalia Journal: Biochem Pharmacol Date: 2020-07-25 Impact factor: 5.858
Authors: Pawan Noel; Krutika Patel; Chandra Durgampudi; Ram N Trivedi; Cristiane de Oliveira; Michael D Crowell; Rahul Pannala; Kenneth Lee; Randall Brand; Jennifer Chennat; Adam Slivka; Georgios I Papachristou; Asif Khalid; David C Whitcomb; James P DeLany; Rachel A Cline; Chathur Acharya; Deepthi Jaligama; Faris M Murad; Dhiraj Yadav; Sarah Navina; Vijay P Singh Journal: Gut Date: 2014-12-10 Impact factor: 23.059
Authors: Krutika Patel; Ram N Trivedi; Chandra Durgampudi; Pawan Noel; Rachel A Cline; James P DeLany; Sarah Navina; Vijay P Singh Journal: Am J Pathol Date: 2015-01-08 Impact factor: 4.307
Authors: Mukund P Srinivasan; Kamlesh K Bhopale; Anna A Caracheo; Lata Kaphalia; Bin Gong; Vsevolod L Popov; Paul J Boor; G A Shakeel Ansari; Bhupendra S Kaphalia Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-01-05 Impact factor: 4.052
Authors: Hong Zhang; Patrick Neuhöfer; Liang Song; Björn Rabe; Marina Lesina; Magdalena U Kurkowski; Matthias Treiber; Thomas Wartmann; Sara Regnér; Henrik Thorlacius; Dieter Saur; Gregor Weirich; Akihiko Yoshimura; Walter Halangk; Joseph P Mizgerd; Roland M Schmid; Stefan Rose-John; Hana Algül Journal: J Clin Invest Date: 2013-02-15 Impact factor: 14.808
Authors: Mukund P Srinivasan; Kamlesh K Bhopale; Anna A Caracheo; Lata Kaphalia; Gopalakrishnan Loganathan; Appakalai N Balamurugan; Cristiana Rastellini; Bhupendra S Kaphalia Journal: Alcohol Clin Exp Res Date: 2021-04-02 Impact factor: 3.455